Hypoglycemic effect of exo- and endo-biopolymers produced by submerged mycelial culture of Ganoderma lucidum in streptozotocin-induced diabetic rats

Journal of Microbiology and Biotechnology

Volumn 14, Issue 5, 2004, Pages 972-977

  Yang, Byung Keun ^b   Wilson, Michael A ^a   Cho, Kai Yip ^a   Song, Chi Hyun ^b  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b Daegu University   (South Korea)

Author keywords

Endo biopolymer; Exo biopolymer; Ganoderma lucidum; Hypoglycemic effect; Submerged mycelial culture

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BIOPOLYMER; CHOLESTEROL; GANODERMA LUCIDUM EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STREPTOZOCIN; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; GANODERMA LUCIDUM; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIPOPROTEIN BLOOD LEVEL; MALE; MYCELIUM; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; GANODERMA; GANODERMA LUCIDUM;

EID: 8644282122     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bar-on, H. and P. S. Roheim. 1976. Hyperlipidemia in streptozotocin-treated rats. Diabetes 25: 509-515.
2. Bierman, E. L. 1992. George Lyman Duff memorial lecture: Atherogenesis in diabetes. Arteriosclerosis Thromb. 12: 647-656.
3. Bursch, W. and R. Schulte-Hermann. 1986. Cytoprotective effect of the prostacyclin derivative iloprost against liver cell death induced by the hepatotoxins carbon terachloride and bromobenzen. Klin. Wochenschr. 64(Suppl. 7): 47-50.
4. Cavazzoni, V. and A. Adami. 1992. Exopolysaccharides produced by mycelial edible mushrooms. Ital. J. Food Sci. 1: 9-15.
5. Desbuquois, B. and G. D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocr. 33: 732-738.
6. Duncan, D. M. 1957. Multiple-range tests for correlated and heteroscedastic means. Biometrics 13: 164-170.
7. Folch, J., M. Lees, and G. H. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipid from animal tissue. J. Biol. Chem. 226: 497-503.
8. Foster, D. W. and J. D. MaGarry. 1983. The metabolic derangements and treatment of diabetic ketoacidosis. N. Engl. J. Med. 309: 159-164.
9. Fridewald, W. T., R. I. Levy, and D. S. Fedreicson. 1979. Estimation of concentration of low density cholesterol in plasma, without use of preparative ultracentrifuse. Clin. Chem. 18: 499-508.
10. Furuse, M., C. Kimura, R. T. Mabayo, H. Takahashi, and J. Okumara. 1993. Dietary sorbose prevents and improves hyperglycemia in genetically diabetic mice. J. Nutr. 123: 59-65.
11. Garg, A. and S. M. Grundy. 1990. Management of hyperlipidemia in NIDDM. Diabetes Care 13: 153-169.
12. Goldberg, R. B. 1981. Lipid disorders in diabetes. Diabetes Care 4: 561-572.
13. Gray, A. M. and P. R. Flatt. 1998. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J. Endocrinol. 157: 259-266.
14. Grey, N. J., I. Kars, and D. M. Kipnis. 1975. Physiologic mechanism in the development of starvation ketosis in man. Diabetes 24: 10-16.
15. Hayes, T. M. 1972. Plasma lipoproteins in adult diabetes. Clin. Endocrinol. 1: 247-251.
16. Hikino, H., C. Konno, Y. Mirin, and T. Hayashi. 1985. Isolation and hypoglycemic activity of garnodemas A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med. 4: 339-340.
17. Hikino, H. and T. Mizuno. 1989. Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies. Planta Med. 55: 385-389.
18. Junod, A., A. E. Lambert, L. Orci, R. Pictet, A. E. Gonet, and A. E. Renold. 1967. Studies of the diabetogenic action of streptozotocin. Proc. Soc. Exp. Biol. Med. 126: 201-205.
19. Kabir, Y., S. Kimura, and T. Tomura. 1988. Dietary effect of Ganoderma lucidum mushrooms on blood pressure and lipid levels in spontaneously hypertensive rats. J. Nutr. Sci. Mitaminol. (Tokyo) 34: 433-438.
20. Kimura, Y., H. Okuda, and S. Arichi. 1988. Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. Planta Med. 54: 290-294.
21. Lee, K. H., J. W. Lee, M. D. Han, H. Jeong, Y. I. Kim, and D. W. Oh. 1994. Correlation between anti-complementary and antitumor activity of the crude polysaccharide from Ganoderma lucidum IY009. Kor. J. Appl. Microbiol. Bioeng. 22: 45-51.
22. Mendola, J., J. R. Wright, and P. E. Lacy. 1989. Oxygen free radical scavenger and immune destruction of murine low-dose STZ-induced insulitis. Diabetes 38: 379-385.
23. Min, B. S., J. J. Gao, N. Nakamura, and M. Hattori. 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. 48: 1026-1033.
24. Niall, M. G., A. M. Rosaleen, O. Daphne, B. C. Patrick, H. J. Alan, and H. Gerald. 1990. Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes 39: 626-636.
25. Patocka, J. 1999. Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica 42: 123-125.
26. Raabo, E. and T. C. Terkildsen. 1960. On the enzymatic determination of blood glucose. Scand. J. Clin. Lab. Invest. 12: 402-407.
27. Reaven, K. M. 1987. Abnormal lipoprotein metabolism in non-insulin dependent diabetes mellitus. Am. J. Med. 83: 31-40.
28. Sale, F. O., S. Marchesini, P. H. Fishman, and B. A. Berra. 1984. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal. Biochem. 142: 347-350.
29. Shon, K. H., S. H. Kim, and J. W. Choi. 1992. Pretreatment with nicotinamide to prevent the pancreatic enzymes changes by streptozotocin in rats. J. Korean Soc. Food Nutr. 21: 117-123.
30. 2O generation and DNA fragmentation in pancreatic islets. Diabetes 40: 1141-1145.
31. Van Horn, L. V. 1996. Lipid metabolism and choices for persons with diabetes. In Powers, M. A. (ed.). Handbook of Diabetes Medical Nutrition Therapy. Aspen Publishers Inc., Gaithersburg, Maryland.
32. Wang, S. Y., M. L. Hsu, H. C. Hsu, C. H. Tzeng, S. S. Lee, M. S. Shiao, and C. K. Ho. 1997. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 17: 699-705.
33. Yang, B. K., J. B. Park, and C. H. Song. 2002. Hypolipidemic effect of exo-polymer produced in submerged mycelial culture of five different mushrooms. J. Microbiol. Biotechnol. 12: 957-961.
34. Yang, B. K., S. C. Jeong, and C. H. Song. 2002. Hypolipidemic effect of exo- and endo-biopolymers produced from submerged mycelial culture of Ganoderma lucidum in rats. J. Microbiol. Biotechnol. 12: 872-877.
35. Yang, B. K., S. C. Jeong, J. B. Park, S. P. Cho, H. J. Lee, S. Das, J. W. Yun, W. J. Lim, and C. H. Song. 2001. Swimming endurance capacity of mice after administration of exo-polymer produced from submerged mycelial culture of Ganoderma lucidum. J. Microbiol. Biotechnol. 11: 902-905.
36. Yoon, S. Y., S. K. Eo, Y. S. Kim, and S. S. Han. 1994. Anti-microbial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch. Pharm. Res .i] 17: 438-442.
37. Zhang, X. H., H. B. Hu, Y. L. Tang, R. S. Huang, J. F. Luo, and B. K. Hur. 2002. The hepartoprotective effects of polysaccharides isolated from submerged fermentation of Ganoderma lucidum. J. Microbiol. Biotechnol. 12: 367-370.